Cardiac Pacing in the Critical Care Setting

  • Richard H. Hongo
  • Nora F. Goldschlager

Cardiac pacing can play an integral role in the management of critically ill patients. This role is not limited to the appropriate implementation of temporary cardiac pacing, but also includes maximizing therapies already available through a patient’s previously implanted permanent pacemaker or implantable cardioverter-defibrillator (ICD). Complications related to the implanted device can also lead to a need for management within the critical care setting. Finally, a permanent cardiac device can interact, and at times interfere, with therapies such as intravenous monitoring line placement, and external cardioversion and defibrillation.


Ventricular Pace Left Ventricular Lead Cardiac Pace Temporary Pace Lead Fracture 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mark AL. The Bezold-Jarish reflex revisited: clinical implications of inhibitory reflexes originating in the heart. J Am Coll Cardiol 1983;1:90–102.PubMedGoogle Scholar
  2. 2.
    Feigl D, Ashkenazy J, Kishon Y. Early and late atrioventricular block in acute inferior myocardial infarction. J Am Coll Cardiol 1984;4:35–38.PubMedCrossRefGoogle Scholar
  3. 3.
    Sclarovsky S, Strasberg B, Hirshberg A, Arditi A, Lewin RF, Agmon J. Advanced early and late atrioventricular block in acute inferior wall myocardial infarction. Am Heart J 1984;108:19–24.CrossRefPubMedGoogle Scholar
  4. 4.
    Tan AC, Lie KI, Durrer D. Clinical setting and prognostic significance of high grade atrioventricular block in acute inferior myocardial infarction. Am Heart J 1980;99:4–8.CrossRefGoogle Scholar
  5. 5.
    Nicod P, Gilpin E, Dittrich H, Polikar R, Henning H, Ross J Jr. Long-term outcome in patients with inferior myocardial infarction and complete heart block. J Am Coll Cardiol 1988;12:589–594.PubMedGoogle Scholar
  6. 6.
    Gupta PK, Lichstein E, Chadda KD. Heart block complicating acute inferior wall myocardial infarctions. Chest 1976;69:599–604.CrossRefPubMedGoogle Scholar
  7. 7.
    Berger PB, Ruocco NA Jr, Ryan TJ, Frederick MM, Jacobs AK, Faxon DP. Incidence and prognostic implications of heart block complicating inferior myocardial infarction treated with thrombolytic therapy: results from TIMI II. J Am Coll Cardiol 1992;20:533–540.PubMedGoogle Scholar
  8. 8.
    Clemmensen P, Bates ER, Califf RM, et al. Complete atrioventricular block complicating inferior wall acute myocardial infraction treated with reperfusion therapy. Am J Cardiol 1991;67:255–230.CrossRefGoogle Scholar
  9. 9.
    Hindman MC, Wagner GS, JaRo M, et al. The clinical significance of bundle branch block complicating acute myocardial infarction. 1. Clinical characteristics, hospital mortality, and one-year follow-up. Circulation 1978;58:679–688.PubMedGoogle Scholar
  10. 10.
    Hindman MC, Wagner GS, JaRo M, et al. The clinical significance of bundle branch block complicating acute myocardial infarction. 2. Indications for temporary and permanent pacemaker insertion. Circulation 1978;58:689–699.PubMedGoogle Scholar
  11. 11.
    Jones ME, Terry G, Kenmure AC. Frequency and significance of conduction defects in acute myocardial infarction. Am Heart J 1977;94:163–167.CrossRefPubMedGoogle Scholar
  12. 12.
    Kyriakidis MK, Kourouklis CB, Papaioannou JT, Christakos SG, Spanos GP, Avgoustakis DG. Sinus node coronary arteries studied with angiography. Am J Cardiol 1983;51:749–750.CrossRefPubMedGoogle Scholar
  13. 13.
    Go AS, Barron HV, Rundle AC, Ornato JP, Avins AL. Bundle-branch block and in-hospital mortality in acute myocardial infarction. National Registry of Myocardial Infarction 2 Investigators. Ann Intern Med 1998;129:690–697.PubMedGoogle Scholar
  14. 14.
    Melgarejo-Moreno A, Galcerá-Toms J, García-Alberola A, et al. Incidence, clinical characteristics, and prognostic significance of right bundle-branch block in acute myocardial infarction; a study in the thrombolytic era. Circulation 1997;96:1139–1144.PubMedGoogle Scholar
  15. 15.
    Lamas GA, Muller JE, Turi ZG, et al. A simplified method to predict occurrence of complete heart block during acute myocardial infarction. Am J Cardiol 1986;57:1213–1219.CrossRefPubMedGoogle Scholar
  16. 16.
    Thomson IR, Dalton BC, Lappas DG, Lowenstein E. Right bundle-branch block and complete heart block caused by the Swan-Ganz catheter. Anesthesiology 1979;51:359–362.CrossRefPubMedGoogle Scholar
  17. 17.
    Luck JC, Engel TR. Transient right bundle branch block with “Swan-Ganz” catheterization. Am Heart J 1976;92:263–264.CrossRefPubMedGoogle Scholar
  18. 18.
    Morris D, Mulvihill D, Lew WY. Risk of developing complete heart block during bedside pulmonary artery catheterization in patients with left bundle-branch block. Arch Intern Med 1987;147:2005–2010.CrossRefPubMedGoogle Scholar
  19. 19.
    Sprung CL, Elser B, Schein RM, et al. Risk of right-bundle branch block and complete heart block during pulmonary artery catheterization. Crit Care Med 1989;17:1–3.CrossRefPubMedGoogle Scholar
  20. 20.
    Stein PD, Mahur VS, Herman MV, Levine HD. Complete heart block induced during cardiac catheterization of patients with pre-existent bundle-branch block. The hazard of bilateral bundle-branch block. Circulation 1966;34:783–791.PubMedGoogle Scholar
  21. 21.
    Harvey JR, Wyman RM, McKay RG, Baim DS. Use of balloon flotation pacing catheters for prophylactic temporary pacing during diagnostic and therapeutic catheterization procedures. Am J Cardiol 1988;62:941–944.CrossRefPubMedGoogle Scholar
  22. 22.
    Bellocci F, Santarelli P, Di Gennaro M, Ansalone G, Fenici R. The risk of cardiac complications in surgical patients with bifascicular block. A clinical and electrophysiologic study in 98 patients. Chest 1980;77:343–348.CrossRefPubMedGoogle Scholar
  23. 23.
    DiNubile MJ, Calderwood SB, Steinhaus DM, Karchmer AW. Cardiac conduction abnormalities complicating native valve active infective endocarditis. Am J Cardiol 1986;58:1213–1217.CrossRefPubMedGoogle Scholar
  24. 24.
    Arnett EN, Roberts WC. Valve ring abscess in active infective endocarditis. Frequency, location, and clues to clinical diagnosis from the study of 95 necropsy patients. Circulation 1976;54:140–145.PubMedGoogle Scholar
  25. 25.
    Roberts NK, Somerville J. Pathological significance of electrocardiographic changes in aortic valve endocarditis. Br Heart J 1969;31:395–396.PubMedGoogle Scholar
  26. 26.
    Steere AC, Batsford WP, Weinberg M, et al. Lyme carditis: cardiac abnormalities of Lyme disease. Ann Intern Med 1980;93:8–16.PubMedGoogle Scholar
  27. 27.
    el-Sherif N, Zeiler RH, Craelius W, Gough WB, Henkin R. QTU prolongation and polymorphic ventricular tachyarrhythmias due to bradycardia-dependent early afterdepolarizations. Afterdepolarizations and ventricular arrhythmias. Circ Res 1988;63:286–305.PubMedGoogle Scholar
  28. 28.
    Tzivoni D, Banai S, Schuger C, et al. Treatment of torsade de pointes with magnesium sulfate. Circulation 1988;77:392–397.PubMedGoogle Scholar
  29. 29.
    Hohnloser SH, Klingenheben T, Singh BN. Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia. Ann Intern Med 1994;121:529–535.PubMedGoogle Scholar
  30. 30.
    Rankin AC, Pringle SD, Cobbe SM. Acute treatment of torsade de pointes with amiodarone: proarrhythmic and antiarrhythmic association of QT prolongation. Am Heart J 1990;119:185–186.CrossRefPubMedGoogle Scholar
  31. 31.
    Nguyen PT, Scheinman MM, Segar J. Polymorphous ventricular tachycardia: clinical characterization, therapy, and the QT interval. Circulation 1986;74:340–349.PubMedGoogle Scholar
  32. 32.
    Firth BG, Dehmer GJ, Nicod P, Willerson JT, Hillis LD. Effect of increasing heart rate in patients with aortic regurgitation. Effect of incremental atrial pacing on scintigraphic, hemodynamic and thermodilution measurements. Am J Cardiol 1982;49:1860–1867.CrossRefPubMedGoogle Scholar
  33. 33.
    Meyer TE, Sareli P, Marcus RH, Patel J, Berk MR. Beneficial effect of atrial pacing in severe acute aortic regurgitation and role of M-mode echocardiography in determining the optimal pacing interval. Am J Cardiol 1991;67:398–403.CrossRefPubMedGoogle Scholar
  34. 34.
    Pandian NG, Kosowsky BD, Gurewich V. Transfemoral temporary pacing and deep vein thrombosis. Am Heart J 1980;100:847–851.CrossRefPubMedGoogle Scholar
  35. 35.
    Austin JL, Preis LK, Crampton RS, Beller GA, Martin RP. Analysis of pacemaker malfunction and complications of temporary pacing in the coronary care unit. Am J Cardiol 1982;49:301–306.CrossRefPubMedGoogle Scholar
  36. 36.
    Fleischmann KE, Orav EJ, Lams GA, et al. Pacemaker implantation and quality of life in the Mode Selection Trial (MOST). Heart Rhythm 2006;3:653–659.CrossRefPubMedGoogle Scholar
  37. 37.
    Heldman D, Mulvihill D, Nguyen H, et al. True incidence of pacemaker syndrome. Pacing Clin Electrophysiol 1990;13:1742–1750.CrossRefPubMedGoogle Scholar
  38. 38.
    Choo MH, Holmes DR Jr, Gersh BJ, et al. Permanent pacemaker infections: characterization and management. Am J Cardiol 1981;48:559–564.CrossRefPubMedGoogle Scholar
  39. 39.
    Ruiter JH, Degener JE, Van Mechelen R, Bos R. Late purulent pacemaker pocket infection caused by staphylococcus epidermidis: serious complication of in situ management. Pacing Clin Electrophysiol 1985;8:903–907.CrossRefPubMedGoogle Scholar
  40. 40.
    Goldman B, MacGregor DC. Management of infected pacemaker systems. Clin Prog Pacing Electrophysiol 1989;2:220ff.Google Scholar
  41. 41.
    Klug D, Wallet F, Kacet S, Courcol RJ. Detailed bacteriologic tests to identify the origin of transvenous pacing system infections indicate a high prevalence of multiple organisms. Am Heart J 2005;149:322–328.CrossRefPubMedGoogle Scholar
  42. 42.
    Arber N, Pras E, Copperman Y, et al. Pacemaker endocarditis. Report of 44 cases and review of the literature. Medicine 1994;73:299–305.CrossRefPubMedGoogle Scholar
  43. 43.
    Paniagua D, Aldrich HR, Lieberman EH, Lamas GA, Agatston AS. Increased prevalence of significant tricuspid regurgitation in patients with transvenous pacemaker leads. Am J Cardiol 1998;82:1130–1132.CrossRefPubMedGoogle Scholar
  44. 44.
    van Rooden CJ, Molhoek SG, Rosendaal FR, Schalij MJ, Meinders AE, Huisman MV. Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads. J Cardiovasc Electrophysiol 2004;15:1258–1262.CrossRefPubMedGoogle Scholar
  45. 45.
    Goudevenos JA, Reid PG, Adams PC, Holden MP, Williams DO. Pacemaker-induced superior vena cava syndrome: report of four cases and review of the literature. Pacing Clin Electrophysiol 1989;12:1890–1895.CrossRefPubMedGoogle Scholar
  46. 46.
    Chamorro H, Rao G, Wholey MH. Superior vena cava syndrome: a complication of transvenous pacemaker implantation. Radiology 1978;126:377–378.PubMedGoogle Scholar
  47. 47.
    Mazzetti H, Dussaut A, Tentori C, Dussaut E, Lazzari JO. Superior vena cava occlusion and/or syndrome related to pacemaker leads. Am Heart J 1993;125:831–837.CrossRefPubMedGoogle Scholar
  48. 48.
    Hingorani A, Ascher E, Marks N, et al. Morbidity and mortality associated with brachial vein thrombosis. Ann Vasc Surg 2006;28:245–247.Google Scholar
  49. 49.
    Black MD, French GJ, Rasuli P, Bouchard AC. Upper extremity deep venous thrombosis. Underdiagnosed and potentially lethal. Chest 1993;103:1887–1890.CrossRefPubMedGoogle Scholar
  50. 50.
    Reynolds J, Anslinger D, Yore R, Paine R. Transvenous cardiac pacemaker, mural thrombosis, and pulmonary embolism. Am Heart J 1969;78:688–691.CrossRefPubMedGoogle Scholar
  51. 51.
    Nicolosi GL, Charmet PA, Zanuttini D. Large right atrial thrombosis. Rare complication during permanent transvenous endocardial pacing. Br Heart J 1980;43:199–201.CrossRefPubMedGoogle Scholar
  52. 52.
    Bradof J, Sands MJ Jr, Lakin PC. Symptomatic venous thrombosis of the upper extremity complicating permanent transvenous pacing: reversal with streptokinase infusion. Am Heart J 1982;104:1112–1113.CrossRefPubMedGoogle Scholar
  53. 53.
    Meier B. Maker of heart device kept flaw from doctors. New York Times, May 24, 2005.Google Scholar
  54. 54.
    Maisel WH, Moynahan M, Zuckerman BD, et al. Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports. JAMA 1006;295:1944–1946.Google Scholar
  55. 55.
    Alt E, Völker R, Bölmer H. Lead fracture in pacemaker patients. Thorac Cardiovasc Surg 1987;35:101–104.CrossRefPubMedGoogle Scholar
  56. 56.
    Wish M, Swartz J, Cohen A, Cohen R, Fletcher R. Steroid-tipped leads versus porous platinum permanent pacemaker leads: a controlled study. Pacing Clin Electrophysiol 1990;13:1887–1890.CrossRefPubMedGoogle Scholar
  57. 57.
    Radovsky AS, Van Vleet JF. Effects of dexamethasone elution on tissue reaction around stimulating electrodes of endocardial pacing lead in dogs. Am Heart J 1989;117:1288–1298.CrossRefPubMedGoogle Scholar
  58. 58.
    Link MS, Estes NA III, Griffin JJ, et al. Complications of dual chamber pacemaker implantation in the elderly. Pacemaker Selection in the Elderly (PASE) Investigators. J Interv Card Electrophysiol 1998;2:175–179.CrossRefPubMedGoogle Scholar
  59. 59.
    Preston TA, Fletcher RD, Lucchesi BR, Judge RD. Changes in myocardial threshold. Physiologic and pharmacologic factors in patients with implanted pacemakers. Am Heart J 1967;74:235–242.CrossRefPubMedGoogle Scholar
  60. 60.
    Dohrmann ML, Goldschlager NF. Myocardial stimulation threshold in patients with cardiac pacemakers: effect of physiologic variables, pharmacologic agents, and lead electrodes. Cardiol Clin 1985;3:527–537.PubMedGoogle Scholar
  61. 61.
    Hughes JC Jr, Tyers GF, Torman HA. Effects of acid-base imbalance on myocardial pacing thresholds. J Thorac Cardiovasc Surg 1975;69:743–746.PubMedGoogle Scholar
  62. 62.
    Westerholm CJ. Threshold studies in transvenous cardiac pacemaker treatment. Direct measurement with special reference to short and long term stimulation and influence of certain metabolic, respiratory and pharmacological factors. Scand J Thorac Cardiovasc Surg 1971;8(Suppl):1–35.Google Scholar
  63. 63.
    Gettes LS, Shabetai R, Downs TA, Surawicz B. Effect of changes in potassium and calcium concentrations on diastolic threshold and strength-interval relationships of the human heart. Ann NY Acad Sci 1969;167:693–705.CrossRefPubMedGoogle Scholar
  64. 64.
    Lee D, Greenspan K, Edmands RE, et al. The effect of electrolyte alteration on stimulus requirement of cardiac pacemakers [abstract]. Circulation 1968;38(Suppl):VI–124.Google Scholar
  65. 65.
    Surawicz B, Chlebus H, Reeves JT, Gettes LS. Increase of ventricular excitability threshold by hyperpotassemia. JAMA 1965;191:1049–1054.PubMedGoogle Scholar
  66. 66.
    Mohan JC, Kaul U, Bhatia ML. Acute effects of anti-arrhythmic drugs on cardiac pacing threshold. Acta Cardiologica 1984;39:191–201.PubMedGoogle Scholar
  67. 67.
    Brandfonbrener M, Kronholm J, Jones HR. The effect of serum potassium concentration on quinidine toxicity. J Pharmacol Exp Ther 1966;154:250–254.PubMedGoogle Scholar
  68. 68.
    Khastgir T, Lattuca J, Aarons D, et al. Ventricular pacing threshold and time to capture postdefibrillation in patients undergoing implantable cardioverter-defibrillator implantation. Pacing Clin Electrophysiol 1991;14:768–772.CrossRefPubMedGoogle Scholar
  69. 69.
    Guarnieri T, Datorre SD, Bondke H, Brinker J, Myers S, Levine JH. Increased pacing threshold after an automatic defibrillator shock in dogs: effect of class I and class II antiarrhythmic drugs. Pacing Clin Electrophysiol 1988;11:1324–1330.CrossRefPubMedGoogle Scholar
  70. 70.
    Dahl CF, Ewy GA, Warner ED, Thomas ED. Myocardial necrosis from direct current countershock: effect of paddle electrode size and time interval between discharges. Circulation 1974;50:956–960.PubMedGoogle Scholar
  71. 71.
    Lau FYK, Bilitch M, Wintrob HJ. Protection of implanted pacemakers from excessive electrical energy of DC shock. Am J Cardiol 1969;23:244–249.CrossRefPubMedGoogle Scholar
  72. 72.
    Waller D, Callies F, Langenfeld H. Adverse effects of direct current cardioversion on cardiac pacemakers and electrodes. Is external cardioversion contraindicated in patients with permanent pacing systems? Europace 2004;6:165–168.CrossRefPubMedGoogle Scholar
  73. 73.
    Altamura G, Bianconi L, Lo Bianco F, et al. Transthoracic DC shock may represent a serious hazard in pacemaker dependent patients. Pacing Clin Electrophysiol 1995;18:194–198.CrossRefPubMedGoogle Scholar
  74. 74.
    Martin ET. Can cardiac pacemakers and magnetic resonance imaging systems co-exist? Eur Heart J 2005;26:325–327.CrossRefPubMedGoogle Scholar
  75. 75.
    Del Ojo JL, Moya F, Villalba J, et al. Is magnetic resonance imaging safe in cardiac pacemaker recipients? Pacing Clin Electrophysiol 2005;28:274–278.CrossRefPubMedGoogle Scholar
  76. 76.
    Nazarian S, Roguin A, Zviman MM, et al. Clinical utility and safety of a protocol for noncardiac and cardiac magnetic resonance imaging of patients with permanent pacemakers and implantable-cardioverter defibrillators at 1.5 Tesia. Circulation 2006;114:1277–1284.CrossRefPubMedGoogle Scholar
  77. 77.
    Gimbel JR, Kanal E, Schwartz MK, Wilkoff BL. Outcome of magnetic resonance imaging in selected patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2005;28:270–273.CrossRefPubMedGoogle Scholar
  78. 78.
    Martin ET, Coman JA, Shellock FG, Pulling CC, Fair R, Jenkins K. Magnetic resonance imaging and cardiac pacemaker safety at 1.5-Tesla. J Am Coll Cardiol 2004;43:1315–1325.CrossRefPubMedGoogle Scholar
  79. 79.
    Aaronson KD, Schwartz JS, Chen TM, et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997;95:2660–2667.PubMedGoogle Scholar
  80. 80.
    Hunt SA, ACC/AHA Task Force. ACC/AHA guideline update for the diagnosis and management of chronic heart failure in the adult. J Am Coll Cardiol 2005;46:1–82.CrossRefGoogle Scholar
  81. 81.
    Abraham WT, Fisher WG, Smith AL, et al for the MIRACLE Study Group. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845–1853.CrossRefPubMedGoogle Scholar
  82. 82.
    Cleland JG, Daubert JC, Erdmann E, et al. For the CARE-HF Study Investigators. The effects of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539–1549.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Richard H. Hongo
    • 1
  • Nora F. Goldschlager
    • 2
  1. 1.San Francisco General HospitalUniversity of California San Francisco School of MedicineSan FranciscoUSA
  2. 2.ECG Laboratory and Coronary Care UnitUniversity of California San Francisco School of MedicineSan FranciscoUSA

Personalised recommendations